Privia Health Group, Inc.
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-77.5% vs price
Base Case (Median)
-75.1% vs price
Bull Case (75th pct.)
21.5% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $3199.09 | 14779.5% | High (40%) |
| PE Comparable | $4.67 | -78.3% | Medium (25%) |
| Growth Trajectory DCF | $33.05 | 53.7% | Medium (20%) |
| Graham Number | $5.34 | -75.2% | Medium (40%) |
| EV/EBITDA | $4.41 | -79.5% | Medium (20%) |
| Earnings Power Value | $5.39 | -74.9% | Medium (50%) |
Based on 6 out of 8 methods, PRVA appears fairly valued at the current price of $21.50. The base case fair value of $5.36 implies 75.1% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.